to evaluate novel potentially protective vaccines to identify new candidate vaccines for future clinical testing for SARS-CoV-2 prevention
- Funded by Gates Foundation
- Total publications:0 publications
Grant number: INV-019081
Grant search
Key facts
Disease
COVID-19start year
2020Known Financial Commitments (USD)
$574,923Funder
Gates FoundationPrincipal Investigator
N/A
Research Location
United States of AmericaLead Research Institution
Gritstone bio, Inc.Research Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
N/A